Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up

BACKGROUND: Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) is considered safe and effective. Evidence of benefit from GM-CSG inhalation for mild to moderate aPAP patients is limited. METHODS: In this multicenter, ran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Tian, Xinlun, Yang, Yanli, Chen, Lulu, Sui, Xin, Xu, Wenshuai, Li, Xue, Guo, Xiaobei, Liu, Lingshan, Situ, Yusen, Wang, Jun, Zhao, Yang, Meng, Shuzhen, Song, Wei, Xiao, Yonglong, Xu, Kai-Feng
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330972/
https://ncbi.nlm.nih.gov/pubmed/32615994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01450-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados